HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia.

Abstract
The pathophysiology of ineffective erythropoiesis in β-thalassemia is poorly understood. We report that RAP-011, an activin receptor IIA (ActRIIA) ligand trap, improved ineffective erythropoiesis, corrected anemia and limited iron overload in a mouse model of β-thalassemia intermedia. Expression of growth differentiation factor 11 (GDF11), an ActRIIA ligand, was increased in splenic erythroblasts from thalassemic mice and in erythroblasts and sera from subjects with β-thalassemia. Inactivation of GDF11 decreased oxidative stress and the amount of α-globin membrane precipitates, resulting in increased terminal erythroid differentiation. Abnormal GDF11 expression was dependent on reactive oxygen species, suggesting the existence of an autocrine amplification loop in β-thalassemia. GDF11 inactivation also corrected the abnormal ratio of immature/mature erythroblasts by inducing apoptosis of immature erythroblasts through the Fas-Fas ligand pathway. Taken together, these observations suggest that ActRIIA ligand traps may have therapeutic relevance in β-thalassemia by suppressing the deleterious effects of GDF11, a cytokine which blocks terminal erythroid maturation through an autocrine amplification loop involving oxidative stress and α-globin precipitation.
AuthorsMichael Dussiot, Thiago T Maciel, Aurélie Fricot, Céline Chartier, Olivier Negre, Joel Veiga, Damien Grapton, Etienne Paubelle, Emmanuel Payen, Yves Beuzard, Philippe Leboulch, Jean-Antoine Ribeil, Jean-Benoit Arlet, Francine Coté, Geneviève Courtois, Yelena Z Ginzburg, Thomas O Daniel, Rajesh Chopra, Victoria Sung, Olivier Hermine, Ivan C Moura
JournalNature medicine (Nat Med) Vol. 20 Issue 4 Pg. 398-407 (Apr 2014) ISSN: 1546-170X [Electronic] United States
PMID24658077 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • ACE-011
  • Bone Morphogenetic Proteins
  • Fas Ligand Protein
  • GDF11 protein, human
  • Gdf11 protein, mouse
  • Growth Differentiation Factors
  • Hematinics
  • Ligands
  • Reactive Oxygen Species
  • Recombinant Fusion Proteins
  • fas Receptor
  • Activin Receptors, Type II
  • activin receptor type II-A
Topics
  • Activin Receptors, Type II (metabolism)
  • Animals
  • Apoptosis (physiology)
  • Autocrine Communication (physiology)
  • Bone Morphogenetic Proteins (antagonists & inhibitors, metabolism)
  • Cell Differentiation
  • Disease Models, Animal
  • Erythroblasts (metabolism)
  • Erythropoiesis (drug effects)
  • Fas Ligand Protein
  • Gene Amplification (physiology)
  • Growth Differentiation Factors (antagonists & inhibitors, metabolism)
  • Hematinics (pharmacology)
  • Ligands
  • Mice
  • Oxidative Stress (physiology)
  • Reactive Oxygen Species
  • Recombinant Fusion Proteins (pharmacology)
  • Signal Transduction
  • beta-Thalassemia (metabolism)
  • fas Receptor

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: